To include your compound in the COVID-19 Resource Center, submit it here.
Zambon granted US WorldMeds exclusive, U.S. rights to market Parkinson’s disease drug Xadago safinamide. Zambon
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury